Showing results (2421-2430 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|June 18, 2009
Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamilMilica Pesić, Ana Podolski, Ljubisa Rakić, et al.
Investigational New Drugs|September 5, 2009
Studies on the neuroprotective role of Piper longum in C6 glioma induced ratsUmadevi Subramanian, Sharmila Poongavanam, A J Vanisree
Investigational New Drugs|August 28, 2009
Synthesis and biological properties of oxazolinodaunorubicin--a new derivative of daunorubicin with a modified daunosamine moietyMalgorzata Lukawska, Joanna Wietrzyk, Adam Opolski, et al.
Investigational New Drugs|September 23, 2009
NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growthMaria Papaioannou, Sonja Schleich, Daniela Roell, et al.
Investigational New Drugs|September 25, 2009
Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplificationSubhasree Roy Choudhury, Surajit Karmakar, Naren L Banik, et al.
Investigational New Drugs|September 18, 2009
Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutationsIn Hae Park, Jin Young Kim, Jae In Jung, et al.
Investigational New Drugs|September 18, 2009
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancerIsamu Okamoto, Masaki Miyazaki, Ryotaro Morinaga, et al.
Investigational New Drugs|April 30, 2010
Characterization of the potency of epidermal growth factor (EGFR)-DNA targeting combi-molecules containing a hydrolabile carbamate at the 3-position of the triazene chainMeaghan MacPhee, Zakaria Rachid, Margarita Todorova, et al.
Investigational New Drugs|June 25, 2010
A phase I study of topotecan and gemcitabine in advanced solid tumorsDerek S Serna, Tanios Bekaii-Saab, Eric H Kraut
Investigational New Drugs|June 12, 2014
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neckDaniel W Bowles, Neil Senzer, Diana Hausman, et al.
Pageof 372